Anthera Pharmaceuticals Inc (ANTH)
0.0001
0.00 (0.00%)
USD |
OTCM |
Nov 05, 10:24
Anthera Pharmaceuticals Total Liabilities (Quarterly): 3.35M for March 31, 2018
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2018 | 3.35M |
December 31, 2017 | 9.168M |
September 30, 2017 | 8.025M |
June 30, 2017 | 9.948M |
March 31, 2017 | 21.20M |
December 31, 2016 | 11.00M |
September 30, 2016 | 23.25M |
June 30, 2016 | 10.18M |
March 31, 2016 | 8.036M |
December 31, 2015 | 8.468M |
September 30, 2015 | 12.14M |
June 30, 2015 | 10.16M |
March 31, 2015 | 8.457M |
December 31, 2014 | 5.751M |
September 30, 2014 | 12.43M |
June 30, 2014 | 13.57M |
March 31, 2014 | 21.40M |
December 31, 2013 | 22.66M |
September 30, 2013 | 21.38M |
Date | Value |
---|---|
June 30, 2013 | 22.65M |
March 31, 2013 | 23.10M |
December 31, 2012 | 29.97M |
September 30, 2012 | 38.98M |
June 30, 2012 | 43.21M |
March 31, 2012 | 47.50M |
December 31, 2011 | 50.41M |
September 30, 2011 | 47.92M |
June 30, 2011 | 45.65M |
March 31, 2011 | 40.49M |
December 31, 2010 | 8.005M |
September 30, 2010 | 4.838M |
June 30, 2010 | 3.231M |
March 31, 2010 | 4.304M |
December 31, 2009 | 18.17M |
September 30, 2009 | 19.47M |
June 30, 2009 | 8.817M |
December 31, 2008 | 8.494M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 2.376M |
FluoroPharma Medical Inc | 10.51M |
Evolutionary Genomics Inc | 7.946M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 2.406M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.811M |
Shareholders Equity (Quarterly) | 5.461M |